Companies: 49,260 Total Market Cap: 131872101107354.76

Shukra Pharmaceuticals Limited

BOM-524632
Pharmaceutical Preparations
Rank #26507
Market Cap 71.75 M
Volume 530,053
Price 0.17
Change (%) 3.86%
Country or region India India

Shukra Pharmaceuticals Limited's latest marketcap:

71.75 M

As of 05/22/2025, Shukra Pharmaceuticals Limited's market capitalization has reached $71.75 M. According to our data, Shukra Pharmaceuticals Limited is the 26507th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 71.75 M
Revenue (ttm) 3.88 M
Net Income (ttm) 950,717.61
Shares Out 437.88 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date 09/23/2024
Earnings Date 05/26/2025
Market Cap Chart
Data Updated: 05/22/2025

Shukra Pharmaceuticals Limited's yearly market capitalization.

Shukra Pharmaceuticals Limited has seen its market value grow from ₹63.41 M to ₹6.17 B since 2020, representing a total increase of 9,629.91% and an annual compound growth rate (CAGR) of 183.73%.
Date Market Cap Change (%)
05/22/2025 ₹6.17 B -6.94%
12/31/2024 ₹5.97 B 340.79%
12/29/2023 ₹1.35 B 554.74%
12/30/2022 ₹206.90 M 58.55%
12/30/2021 ₹130.50 M 105.8%
12/31/2020 ₹63.41 M

Company Profile

About Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited is a leading pharmaceutical company engaged in the development, manufacturing, marketing, and export of a diverse range of drugs and dosage forms. Operating in India and internationally, the company serves the healthcare sector with high-quality pharmaceutical solutions.

Product Portfolio

The company offers a comprehensive range of pharmaceutical products, including:

  • Macrolides & Quinolones
  • Anti-bacterial, Anti-fungal & Anti-viral medications
  • Anti-malarial & Anti-protozoal treatments
  • Anti-depressants & Anti-manic drugs
  • Anti-emetic & Anti-ulcer formulations
  • Beta blockers & Diuretics
  • Analgesics & Muscle relaxants
  • Anti-tuberculosis & Vitamin products
  • Antibiotics (Penicillin & Cephalosporin)

Company Background

Originally incorporated in 1993 as Relish Pharmaceuticals Limited, the company rebranded to Shukra Pharmaceuticals Limited in August 2016. Headquartered in Ahmedabad, India, the company has built a strong reputation in the pharmaceutical industry over the years.

Frequently Asked Questions

As of 05/22/2025, Shukra Pharmaceuticals Limited (including the parent company, if applicable) has an estimated market capitalization of $71.75 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Shukra Pharmaceuticals Limited global market capitalization ranking is approximately 26507 as of 05/22/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region India
Founded 1993
IPO Date n/a
Employees 182
CEO Dakshesh Shah
Sector
Industry Pharmaceutical Preparations
Address Veer House
Ahmedabad, 380054
India
Website https://www.shukrapharmaceuticals.com
People Also Watch
Ipsen S.A.
138.73 3.86%
Krka, d. d.
210.02 3.86%
BUD-RICHTER
28.78 3.86%
Hugel
256.32 3.86%